Serum P-Cresyl Sulfate Is Associated with Peripheral Arterial Stiffness in Chronic Hemodialysis Patients
Diagnostics · 16.09.2025 · 15 (18) · 2353
DOI: 10.3390/diagnostics15182353 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 16.09.2025. Verfasst von Yahn-Bor Chern und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, St. Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, ON M5B 1W8, Canada. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Buddhist Tzu Chi Medical Foundation.
Abstract (Originalsprache)
Background/Objectives: Arterial stiffness is a major cardiovascular risk factor in patients with hemodialysis (HD). We conducted a cross-sectional study aimed at determining the relationship between serum p-Cresyl sulfate (PCS) and peripheral arterial stiffness (PAS), defined via the cardio-ankle vascular index (CAVI), in 110 patients receiving chronic HD.
Methods
Participants were divided into PAS (CAVI ≥ 9.0) and control (CAVI < 9.0) groups. Serum PCS level was measured by high-performance liquid chromatography-mass spectrometry.
Results
PAS was detected in 37 (33.6%) patients. The PAS patients were older and had higher SBP, more diabetes, and higher serum PCS and C-reactive protein (CRP) than the control group. Upon multivariate analysis, PAS was significantly associated with PCS (adjusted odds ratio: 1.238 per 1 mg/L increase, 95% confidence interval [CI]: 1.119–1.371, p < 0.001). The CAVI, advanced age, and CRP demonstrated a significant correlation with PCS, as evidenced by the correlation analysis conducted. Area under the receiver operating characteristic curve analysis showed that PCS had a good diagnostic value for PAS (AUC: 0.872, 95% CI: 0.805–0.939; p < 0.001), and the optimal cutoff value was 24.29 mg/L.
Conclusions
PCS demonstrates great potential as a biomarker in the diagnosis of arterial stiffness.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, St. Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, ON M5B 1W8, Canada.
- Division of Nephrology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan.
- School of Medicine, Tzu Chi University, Hualien 97004, Taiwan.
- Graduate Institute of Clinical Pharmacy, School of Medicine, Tzu Chi University, Hualien 97004, Taiwan.
- School of Pharmacy, Tzu Chi University, Hualien 97004, Taiwan.
- Division of Nephrology, Department of Internal Medicine, Hsin-Jen Hospital, New Taipei City 24243, Taiwan.
ORCID-Profile: Yahn-Bor Chern, Chih-Hsien Wang, Chin-Hung Liu, Jen-Pi Tsai, Bang-Gee Hsu
Förderung
- Buddhist Tzu Chi Medical Foundation
Zitieren
APA
Chern, Y. B., Wang, C. H., Liu, C. H., Liou, H. H., Tsai, J. P., & Hsu, B. G. (2025). Serum P-Cresyl Sulfate Is Associated with Peripheral Arterial Stiffness in Chronic Hemodialysis Patients. Diagnostics, 15(18), 2353. https://doi.org/10.3390/diagnostics15182353
Vancouver
Chern YB, Wang CH, Liu CH, Liou HH, Tsai JP, Hsu BG. Serum P-Cresyl Sulfate Is Associated with Peripheral Arterial Stiffness in Chronic Hemodialysis Patients. Diagnostics. 2025;15(18):2353. doi:10.3390/diagnostics15182353
BibTeX
@article{Chern2025,
author = {Chern, Yahn-Bor and Wang, Chih-Hsien and Liu, Chin-Hung and Liou, Hung-Hsiang and Tsai, Jen-Pi and Hsu, Bang-Gee},
title = {Serum P-Cresyl Sulfate Is Associated with Peripheral Arterial Stiffness in Chronic Hemodialysis Patients},
journal = {Diagnostics},
year = {2025},
volume = {15},
number = {18},
pages = {2353},
doi = {10.3390/diagnostics15182353}
}
EUVIMED